Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor - PubMed (original) (raw)
Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor
Shideng Bao et al. Cancer Res. 2006.
Abstract
Malignant gliomas are highly lethal cancers dependent on angiogenesis. Critical tumor subpopulations within gliomas share characteristics with neural stem cells. We examined the potential of stem cell-like glioma cells (SCLGC) to support tumor angiogenesis. SCLGC isolated from human glioblastoma biopsy specimens and xenografts potently generated tumors when implanted into the brains of immunocompromised mice, whereas non-SCLGC tumor cells isolated from only a few tumors formed secondary tumors when xenotransplanted. Tumors derived from SCLGC were morphologically distinguishable from non-SCLGC tumor populations by widespread tumor angiogenesis, necrosis, and hemorrhage. To determine a potential molecular mechanism for SCLGC in angiogenesis, we measured the expression of a panel of angiogenic factors secreted by SCLGC. In comparison with matched non-SCLGC populations, SCLGC consistently secreted markedly elevated levels of vascular endothelial growth factor (VEGF), which were further induced by hypoxia. In an in vitro model of angiogenesis, SCLGC-conditioned medium significantly increased endothelial cell migration and tube formation compared with non-SCLGC tumor cell-conditioned medium. The proangiogenic effects of glioma SCLGC on endothelial cells were specifically abolished by the anti-VEGF neutralizing antibody bevacizumab, which is in clinical use for cancer therapy. Furthermore, bevacizumab displayed potent antiangiogenic efficacy in vivo and suppressed growth of xenografts derived from SCLGC but limited efficacy against xenografts derived from a matched non-SCLGC population. Together these data indicate that stem cell-like tumor cells can be a crucial source of key angiogenic factors in cancers and that targeting proangiogenic factors from stem cell-like tumor populations may be critical for patient therapy.
Similar articles
- Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation.
Dong J, Zhao Y, Huang Q, Fei X, Diao Y, Shen Y, Xiao H, Zhang T, Lan Q, Gu X. Dong J, et al. Stem Cell Rev Rep. 2011 Mar;7(1):141-52. doi: 10.1007/s12015-010-9169-7. Stem Cell Rev Rep. 2011. PMID: 20697979 - Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma.
Arbab AS. Arbab AS. Histol Histopathol. 2012 May;27(5):549-57. doi: 10.14670/HH-27.549. Histol Histopathol. 2012. PMID: 22419019 Free PMC article. Review. - Angiogenesis in gliomas: biology and molecular pathophysiology.
Fischer I, Gagner JP, Law M, Newcomb EW, Zagzag D. Fischer I, et al. Brain Pathol. 2005 Oct;15(4):297-310. doi: 10.1111/j.1750-3639.2005.tb00115.x. Brain Pathol. 2005. PMID: 16389942 Free PMC article. Review.
Cited by
- Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients.
Laviv Y, Regev O, Kanner AA, Fichman S, Limon D, Siegal T, Yust-Katz S, Benouaich-Amiel A. Laviv Y, et al. J Neurooncol. 2024 Sep 24. doi: 10.1007/s11060-024-04828-7. Online ahead of print. J Neurooncol. 2024. PMID: 39316315 - Unlocking the Therapeutic Potential of Oral Cancer Stem Cell-Derived Exosomes.
Kumar P, Lakhera R, Aggarwal S, Gupta S. Kumar P, et al. Biomedicines. 2024 Aug 9;12(8):1809. doi: 10.3390/biomedicines12081809. Biomedicines. 2024. PMID: 39200273 Free PMC article. Review. - Three-dimensional imaging of upper tract urothelial carcinoma improves diagnostic yield and accuracy.
Fukumoto K, Kanatani S, Jaremko G, West Z, Li Y, Takamatsu K, Al Rayyes I, Mikami S, Niwa N, Axelsson TA, Tanaka N, Oya M, Miyakawa A, Brehmer M, Uhlén P. Fukumoto K, et al. JCI Insight. 2024 Jul 22;9(14):e175751. doi: 10.1172/jci.insight.175751. JCI Insight. 2024. PMID: 39133649 Free PMC article. - STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer.
Liu X, Chen Y, Li Y, Bai J, Zeng Z, Wang M, Dong Y, Zhou Y. Liu X, et al. Biol Direct. 2024 Jul 30;19(1):59. doi: 10.1186/s13062-024-00506-w. Biol Direct. 2024. PMID: 39080743 Free PMC article. - Cancer biotherapy: review and prospect.
Liu Q, Ma H. Liu Q, et al. Clin Exp Med. 2024 May 27;24(1):114. doi: 10.1007/s10238-024-01376-2. Clin Exp Med. 2024. PMID: 38801637 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical